
Metadon 35mg Tablet MR
Marketer
Daxia Healthcare
Salt Composition
Trimetazidine (35mg)
Overview Metadon 35mg Tablet MR
Methadone MR 35mg tablets are prescribed for angina pectoris, a type of heart-related chest pain. This medication acts to prevent future angina episodes but won't alleviate an attack already in progress. It's employed either independently or alongside other cardiac medications. Dosage and frequency, as determined by your physician, should be adhered to consistently, regardless of food intake. Regular use, even during symptom-free periods, is crucial for sustained efficacy and minimizing future cardiac events. Discontinuing treatment may lead to angina recurrence. Adopting a healthier lifestyle – including smoking cessation, moderate alcohol consumption, a balanced diet, regular physical activity, and stress management – further supports cardiovascular well-being. Potential side effects include, but aren't limited to: lightheadedness, headache, stomach upset, diarrhea, indigestion, nausea, vomiting, skin rashes, itching, hives, and fatigue. Report any persistent or troublesome side effects to your doctor. Prior to commencing treatment, inform your physician of any pre-existing liver or kidney conditions, pregnancy, breastfeeding, or other concurrent medications.
Primary Ingredients of Metadon 35mg Tablet MR
No text was provided to rephrase. Please provide the text you would like me to rewrite.
Uses of Metadon 35mg Tablet MR
Managing chest pain associated with angina pectoris
Major Benefits of Metadon 35mg Tablet MR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 35mg Metadon Modified-Release tablet should be administered with a meal.
Common Side effects of Metadon 35mg Tablet MR:
- Dizziness
- Headache
- Nausea
- Vomiting
- Weakness
- Rash
- Abdominal pain
- Indigestion
- Itching
- Diarrhea
- Hives
How to use Metadon 35mg Tablet MR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metadon 35mg Modified-Release Tablet should be taken with a meal.
How Metadon 35mg Tablet MR works:
Morphine-like analgesic Metadon MR 35mg tablets offer anti-anginal effects. By altering cardiac metabolism, favoring glucose over fatty acids, they reduce the heart's oxygen demand, thereby improving cardiac efficiency.
SAFETY ADVICE
AlcoholUNSAFE
Combining 35mg extended-release methadone tablets with alcohol can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Data on the use of 35mg modified-release Metadon tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of 35mg modified-release metadone tablets with breastfeeding are lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking a 35mg modified-release metadone tablet might reduce alertness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Methadone 35mg MR tablets require careful administration in individuals with impaired renal function. Dosage modification of Methadone 35mg MR tablets may be necessary. Physician consultation is advised. Methadone 35mg MR tablets are contraindicated in patients exhibiting severe kidney disease.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of 35mg modified-release Metadon tablets to individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Metadon 35mg Tablet MR :
Should you forget to take a 35mg extended-release methadone tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metadon 35mg Tablet MR
| Label | Value |
|---|---|
| Chemical Type | Benzylamines |
| Developing Habits | No. |
| Treatment Category | Heart |
| Behavior Class | Fatty acid and sodium channel inhibitor |
